Chemokines: potent mediators of hepatic inflammation and fibrosis in chronic liver diseases
Journal Title: Annals of Hepatology - Year 2014, Vol 13, Issue 1
Abstract
Authors and Affiliations
Priya Handa, Kris V. Kowdley
Keywords
Related Articles
- EP ID EP78370
- DOI -
- Views 112
- Downloads 0
Sofosbuvir and daclatasvir in mono- and HIV-coinfected patients with recurrent hepatitis C after liver transplant
Background and aims. Pegylated interferon (Peg-INF) and ribavirin (RBV) based therapy is suboptimal and poorly tolerated. We evaluated the safety, tolerability and efficacy of a 24-week course of sofosbuvir plus daclata...
High ghrelin and obestatin levels and low risk of developing fatty liver
Aim. Obesity and insulin resistance are associated with nonalcoholic fatty liver disease (NAFLD). It was recently reported that the ratio between levels of ghrelin and obestatin is also associated with obesity and insuli...
Incidence and prognostic factors associated with biliary atresia in western India
Aim: To estimate the incidence of Biliary Atresia(BA) amongst Neonatal Cholestatic Syndromes (NCS) and determine prognostic factors in BA patients who have undergone Kasai’s portoenterostomy. Study design- Retrospective...
Survival of hepatitis C-infected haemophilia patients is predicted by presence of cirrhosis but not by anti-viral treatment
Background/Purpose. Hepatitis C (HCV) is a major cause of morbidity and mortality in haemophilia patients who received clotting factor concentrates before the availability of virus-inactivated factors in the mid-1980s. R...
Impact of the severity of end-stage liver disease in cardiac structure and function
[b]Background[/b]. The impact of end-stage liver disease (ESLD) in cardiac remodeling of patients with cirrhosis is unknown. Our aim was to correlate the severity of ESLD with morphologic and functional heart changes. [b...